Getting a GLP-1 prescription without an in-person visit is not the same as ordering medication from a website. A legitimate telehealth provider must collect your medical history, review lab results, and have a licensed clinician evaluate whether GLP-1 therapy is appropriate before any prescription is written. This guide covers how the process works, what to expect, and what to avoid.
- A legitimate telehealth GLP-1 prescription requires clinical evaluation, lab review, and a documented BMI or diagnostic history — not just a questionnaire.
- Labs typically needed include HbA1c, comprehensive metabolic panel, thyroid panel (TSH), and a lipid panel, drawn within 3-6 months.
- Starting doses are always the lowest available — semaglutide 0.25 mg weekly or tirzepatide 2.5 mg weekly — with titration increases every 4 weeks.
- The full process from intake to prescription typically takes 1-2 weeks, faster if you already have recent labs.
- Contraindications include personal or family history of medullary thyroid carcinoma, MEN 2, active pancreatitis, and severe gastroparesis.
- Compounded GLP-1 medications are now FDA-restricted; GoodLife Health prescribes only FDA-approved branded medications (Wegovy, Zepbound).
TL;DR
A GLP-1 prescription requires three things: a clinical evaluation by a licensed provider, recent lab results showing metabolic markers (HbA1c, fasting glucose, lipids, thyroid function), and a documented BMI or diagnostic history supporting medical need. Verdict: you can get a GLP-1 prescription through telehealth without an in-person visit, but only if the provider orders labs, reviews them, and makes a clinical decision based on your results — not a questionnaire alone. Any service that prescribes GLP-1 medication after a 5-minute form without labs is not practicing medicine; it is selling a product.
Why This Matters
GLP-1 receptor agonists — semaglutide (Wegovy, Ozempic) and tirzepatide (Zepbound, Mounjaro) — are not mild appetite suppressants. They are powerful metabolic drugs that affect insulin secretion, gastric emptying, thyroid function, and pancreatic activity. The FDA requires a clinical evaluation before prescription because these medications have real contraindications: personal or family history of medullary thyroid carcinoma (MTC), multiple endocrine neoplasia syndrome type 2 (MEN 2), active pancreatitis, and severe gastroparesis. A telehealth provider who skips lab review and clinical evaluation cannot screen for these conditions.
The 2021 STEP 1 trial (semaglutide) and the 2022 SURMOUNT-1 trial (tirzepatide) established the efficacy of these medications for weight loss, but both trials enrolled patients under medical supervision with baseline labs and ongoing monitoring. The safety profile in clinical trials depends on patient selection — the same selection a telehealth clinician must perform before prescribing.
What You'll Need
- A valid government-issued ID (telehealth providers must verify identity)
- Your medical history, including current medications, allergies, and prior diagnoses
- Recent lab results (within 3-6 months) — if you don't have them, the provider should order them
- Your height and current weight (for BMI calculation)
- A list of any family history of thyroid cancer, pancreatitis, or endocrine disorders
- 15-30 minutes for a virtual consultation or clinical review
The Steps
1. Choose a telehealth provider that requires labs before prescribing
A legitimate telehealth provider for GLP-1 therapy will order a comprehensive metabolic panel — or require recent results — before any prescription is written. This is not optional. The labs a provider should review before prescribing GLP-1 include: HbA1c (or fasting glucose), comprehensive metabolic panel (kidney and liver function), thyroid panel (TSH at minimum), and a lipid panel. If a provider offers to prescribe GLP-1 medication after only an online questionnaire with no lab review, that is a red flag. Common mistake: assuming that because the process is online, it doesn't require labs — it does, and the best providers make lab ordering part of the workflow.
2. Complete the intake and clinical evaluation
The intake should include your full medical history, current medications, allergies, BMI, and any relevant diagnostic history (prediabetes, type 2 diabetes, obesity, insulin resistance). A clinician — not an algorithm — should review this information. Some telehealth providers conduct a video consultation; others do an asynchronous clinical review where a clinician reviews your intake and labs and messages you with their assessment. Both are legitimate; neither should skip the clinical judgment step. Common mistake: listing only your current medications and forgetting to mention supplements, which can interact with GLP-1 medications (e.g., berberine and GLP-1 both lower blood sugar, increasing hypoglycemia risk).
3. Get your labs drawn
If you don't have recent lab results, the provider should order them. Most telehealth providers partner with national lab networks (Quest, LabCorp) so you can get blood drawn at a local facility. The labs typically required before starting GLP-1 therapy include: HbA1c, fasting glucose, comprehensive metabolic panel (CMP), thyroid-stimulating hormone (TSH), and a lipid panel. Some providers also check fasting insulin and vitamin B12, especially if metformin is part of your history. Common mistake: skipping the lab draw because you feel fine — GLP-1 medications can affect kidney function and thyroid markers, and baseline labs are essential for safe monitoring.
4. Have the clinician review your labs and make a clinical decision
After your labs are available, a licensed clinician reviews them alongside your medical history and makes a determination: whether GLP-1 therapy is appropriate, which medication is best suited, and what starting dose is safest. This is the step that separates a telehealth provider from a prescription mill. The clinician should check for contraindications (thyroid history, pancreatitis risk, kidney function), assess potential drug interactions, and document the clinical rationale for prescribing. Common mistake: assuming the clinician will rubber-stamp the prescription — a good clinician may decline to prescribe if your labs show contraindications or if GLP-1 therapy is not the right clinical choice.
A good clinician may decline to prescribe if your labs show contraindications or if GLP-1 therapy is not the right clinical choice — the clinical judgment step is what separates a telehealth provider from a prescription mill.
5. Receive your prescription and begin the titration protocol
If the clinician determines GLP-1 therapy is appropriate, the prescription is sent to a pharmacy. For branded medications (Wegovy, Zepbound), this goes to a retail or mail-order pharmacy and may require insurance prior authorization. The starting dose is always the lowest available (semaglutide 0.25 mg weekly; tirzepatide 2.5 mg weekly) with a titration schedule that increases the dose every 4 weeks based on tolerance and response. Common mistake: requesting a higher starting dose to see faster results — the titration schedule exists to minimize gastrointestinal side effects and allow your body to adjust.
Starting doses
Titration increases every 4 weeks
| Medication | Starting dose |
|---|---|
| Semaglutide | 0.25 mg weekly |
| Tirzepatide | 2.5 mg weekly |
6. Establish a monitoring plan
GLP-1 therapy is not a one-and-done prescription. A responsible telehealth provider will schedule follow-up check-ins (typically monthly), monitor your response through symptom tracking and periodic labs, and adjust the dose or medication based on your progress. The monitoring plan should include: monthly check-ins via secure messaging or video, follow-up labs at 3 months (HbA1c, kidney function), and a maintenance plan for when you reach your target weight. Common mistake: discontinuing follow-up once you start losing weight — the maintenance phase is where most patients need the most support to prevent weight regain.
Troubleshooting Common Setbacks
Your insurance denied the GLP-1 prescription. The telehealth provider should help with the prior authorization process by submitting clinical documentation supporting medical necessity. If prior auth is denied, ask about manufacturer savings programs (Novo Nordisk Wegovy savings card, Eli Lilly Zepbound savings card) or pharmacy discount programs.
You're experiencing nausea after starting. This is the most common side effect, particularly during dose escalation. Stay hydrated, eat smaller meals, and avoid fatty foods. If nausea is severe or persistent, message your clinician — they may slow the titration schedule or prescribe an antiemetic.
You lost weight initially but progress has stalled. This is common after 3-6 months. The clinician can assess whether a dose adjustment is needed, whether you've hit a temporary plateau, or whether adding a complementary intervention (protein targets, resistance training) would restart progress.
You want to switch from semaglutide to tirzepatide. This is a clinical decision that requires a conversation with your clinician. Tirzepatide (dual GIP/GLP-1 receptor agonist) has shown greater weight loss in head-to-head comparisons, but switching medications requires a new titration from the lowest dose.
Common setbacks
What to do
| Setback | Response |
|---|---|
| Insurance denied the prescription | Ask about prior authorization support and manufacturer savings programs |
| Nausea after starting | Stay hydrated, eat smaller meals, message your clinician about slowing titration |
| Progress stalled after 3-6 months | Clinician assesses dose adjustment, plateau, or added interventions |
| Want to switch semaglutide to tirzepatide | Requires a clinical conversation and a new titration from the lowest dose |
Tools and Resources
- Recent lab results (HbA1c, CMP, TSH, lipid panel) — or ask your telehealth provider to order them
- A medical weight loss membership that includes GLP-1 therapy, lab monitoring, and ongoing clinician support
- A complete medical history including all current medications and supplements
- A scale and a way to track weekly weights (the provider should request these at check-ins)
What to Do Next
If you're considering GLP-1 therapy and want to avoid the in-person visit barrier, the next step is a telehealth evaluation that includes lab ordering, clinical review, and a personalized protocol. A medical weight loss membership at GoodLife Health includes comprehensive lab work, a named clinician who reviews your results, GLP-1 therapy with FDA-approved branded medications, and a structured monitoring plan.
FAQ
Can I get a GLP-1 prescription entirely online? Yes, if the telehealth provider conducts a clinical evaluation, orders or reviews labs, and has a licensed clinician make the prescribing decision. A questionnaire alone is not a clinical evaluation.
Do I need labs before getting prescribed a GLP-1? Yes. A responsible provider will require or order a metabolic panel, thyroid panel, and HbA1c before prescribing. GLP-1 medications affect multiple metabolic systems, and baseline labs are essential for safe monitoring.
What if I don't have insurance? GoodLife Health prescribes FDA-approved branded GLP-1 medications (Wegovy, Zepbound) that you fill at a standard pharmacy. Manufacturer savings programs may reduce the cost. The membership fee covers the clinical relationship, not the medication.
Is a video visit required? Not always. Some telehealth providers conduct asynchronous clinical reviews where a clinician reviews your intake, labs, and history and communicates via secure messaging. Both synchronous (video) and asynchronous reviews are legitimate as long as a licensed clinician makes the prescribing decision.
How long does the process take from intake to prescription? Typically 1-2 weeks: a few days for intake and lab ordering, 2-3 days for lab results, and 1-2 days for clinician review and prescription. If you already have recent labs, the process can be faster.
What are the contraindications for GLP-1 therapy? Personal or family history of medullary thyroid carcinoma (MTC), multiple endocrine neoplasia syndrome type 2 (MEN 2), active or recurrent pancreatitis, and severe gastroparesis. A clinician must screen for these before prescribing.
Can I get compounded semaglutide or tirzepatide online? Compounded GLP-1 medications are now FDA-restricted following the resolution of the national drug shortage. GoodLife Health prescribes exclusively FDA-approved branded medications (Wegovy, Zepbound).
What happens if the clinician decides GLP-1 therapy isn't right for me? A good clinician will explain why and recommend alternatives — which may include lifestyle intervention, a different medication class, or further evaluation of underlying conditions (thyroid, insulin resistance, hormone imbalance).
The difference between a legitimate telehealth GLP-1 prescription and a prescription mill is not the technology — it's whether a licensed clinician reviews your labs, screens for contraindications, and makes a clinical judgment before prescribing.
One Last Thing
The difference between a legitimate telehealth GLP-1 prescription and a prescription mill is not the technology — it's whether a licensed clinician reviews your labs, screens for contraindications, and makes a clinical judgment before prescribing. The online part should make access easier, not bypass the medicine.
Related Guides
Related Reading
- Best GLP-1 for Weight Loss in 2026 | Ranked
- Labs Before Hormone Therapy 2026: The Non-Negotiable Panel
- Best Direct Primary Care Membership Plans 2026
- Best Concierge Medicine Providers 2026 — Ranked
References
- Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). 2022. pubmed.ncbi.nlm.nih.gov/35658024/
- Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). 2021. pubmed.ncbi.nlm.nih.gov/33567185/